Per S.
- Country
- Sweden
- Department
- Academic Specialist Center, SLSO
Research Overview
- An Observational Study of the Efficacy and Usability of OraFID Dispensing Device and Digital Application for Carbidopa and Levodopa Administration in Parkinson's Disease Patients
- Phase II Open-Label Extension Study of Oral Montelukast Sodium for Disease Modification in Mild-Moderate Parkinson’s Disease (MONTPARK_OLE)
- Randomized, Double‑Blind, Placebo‑Controlled 104‑Week Proof‑of‑Concept Study of IV Prasinezumab in GBA‑Mutation Parkinson’s Disease Assessing Cognitive Decline
Data & Insights
Has run more than one trial at 8 of 45 partner sites.
Specializations
Neurodegenerative Disorders
This investigator specializes in clinical research focusing on neurodegenerative movement disorders, with particular emphasis on innovative therapeutic approaches for Parkinson's disease and Progressive Supranuclear Palsy.
- Movement Disorders
- Disease Progression Management
- Neurological Therapeutics
The investigator explores potential disease-modifying treatments for parkinsonian conditions.
Therapeutic Innovation
Research activities center on evaluating novel therapeutic compounds including Exenatide, AMX0035, and Montelukast for neurological conditions.
- Drug Repurposing Studies
- Novel Treatment Approaches
- Long-term Treatment Effects
The investigator examines biological mechanisms and therapeutic efficacy in neurological disorders.
Clinical Assessment
Expertise in evaluating disease progression markers and motor symptom assessment in neurological conditions.
- Disease Progression Monitoring
- Safety Assessment
- Clinical Rating Scales
The investigator utilizes specialized rating scales and assessment tools for measuring therapeutic outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.